Drug Pipeline

Orforglipron Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
13
Active Studies
6
Recruiting
13
Phase 3
1
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT06952530
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and…
overall status: "Recruiting" → "Active Not Recruiting"
2026-05-30 NCT06948422
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and…
overall status: "Recruiting" → "Active Not Recruiting"
2026-05-30 NCT06948435
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and…
overall status: "Recruiting" → "Active Not Recruiting"
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-29 NCT07613307 A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe… Phase 3 Not Yet Recruiting
Active Studies by Phase
Phase 3
13
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06672549 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) Obesity Recruiting
NCT06672939 A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or… Obesity Recruiting
NCT07153471 A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and… Osteoarthritis Recruiting
NCT07202884 A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have… Urinary Incontinence,Stress Recruiting
NCT07223593 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Peripheral Arterial Disease Recruiting
NCT07241390 A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With… Atherosclerosis Cardiovascular Disease Recruiting
NCT06972472 A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2… Obesity Active, Not Recruiting
NCT06972459 A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at… Obesity Active, Not Recruiting
NCT06993792 A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight… Obesity Active, Not Recruiting
NCT06948422 A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and… Hypertension Active, Not Recruiting
NCT06948435 A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and… Hypertension Active, Not Recruiting
NCT06952530 A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and… Hypertension Active, Not Recruiting
NCT07613307 A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe… Diabetes Mellitus, Type 2 Not Yet Recruiting
Sponsors Running Orforglipron Trials
Disease Areas
Get alerts when Orforglipron trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free